Cue Biopharma’s $20 Million Common Stock Offering

Leila Ahmed North America Legal Chronicle
Tagged:

Wilmer Cutler Pickering Hale and Dorr advised Cue Biopharma, and Paul Hastings advised the underwriters on the offering.Cue Biopharma (Nasdaq: CUE), a clinical-stage biopharmaceutical company, announced…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here